Related Articles
Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers
Loss of RUNX3 is significantly associated with advanced tumor grade and stage in endometrial cancers
Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer
Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers
The role of the tumor suppressor RUNX3 in giant cell tumor of the bone